Highlights and Quick Summary
- Annual 3Y Shareholders Equity Growth (per Share) for 2022 was -5.46% (a -101.66% decrease from previous year)
- Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 328.27% (a -528.27% decrease from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Shareholders Equity Growth (per Share) of Dyne Therapeutics, Inc.
Most recent 3Y Shareholders Equity Growth (per Share)of DYN including historical data for past 10 years.Interactive Chart of 3Y Shareholders Equity Growth (per Share) of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. 3Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -5.46% |
| 2021 | – | – | – | – | 328.27% |
| 2018 | – | – | – | – | -76.65% |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology